Evidence map›Paper›PMID 35732373›Full record

ArticleBMJ case reports2022

Mollie Helena McMahon, Nasim Tahir, Meena Balasubramanian

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Mollie Helena McMahonDepartment of Paediatrics, Sheffield Children's Hospital, Sheffield, UK.
Nasim TahirDepartment of Paediatric Radiology, Leeds Children's Hospital, Leeds, West Yorkshire, UK.
Meena BalasubramanianOncology & Metabolism, University of Sheffield, Sheffield, Sheffield, UK m.balasubramanian@sheffield.ac.uk.
Leeds Teaching Hospitals NHS Trust · GBSheffield Children's Hospital · GBSheffield Children's NHS Foundation Trust · GB

Funding

Medical Research Council MR/V037307/1
6 · The paper itself

Abstract

Cutaneous venous malformations frequently present with blue-pink lesions on the skin or mucosal surfaces. They can be problematic for patients who experience pain or unsightly lesions and can also be associated with significant bleeding. A proportion of venous malformations have been noted to occur in families, in particular glomuvenous malformations (GVMs). A 'two-hit' occurrence of genetic pathogenic variants appears to explain the appearance of GVMs, with the initial change in the germline copy of

Indexed as

Glomus TumorSkin NeoplasmsVascular MalformationsAdaptor Proteins, Signal TransducingHumansParaganglioma, Extra-AdrenalAdaptor Proteins, Signal TransducingGLMN protein, humanDermatologyGenetic screening / counsellingInterventional radiologyPaediatrics

Identifiers

PMID35732373
PMCPMC9226952
OpenAlexW4283259252

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.